National Centre for Chronic and Noncommunicable Disease Control and Prevention, Chinese Centre for Disease Control and Prevention, Beijing, China.
Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Lancet Public Health. 2020 Dec;5(12):e682-e691. doi: 10.1016/S2468-2667(20)30254-1.
BACKGROUND: Vision loss is an important public health issue in China, but a detailed understanding of national and regional trends in its prevalence and causes, which could inform health policy, has not been available. This study aimed to assess the prevalence, causes, and regional distribution of vision impairment and blindness in China in 1990 and 2019. METHODS: Data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 were used to estimate the prevalence of moderate and severe vision impairment and blindness in China and compare with other Group of 20 (G20) countries. We used GBD methodology to systematically analyse all available demographic and epidemiological data at the provincial level in China. We compared the age-standardised prevalences across provinces, and the changes in proportion of vision loss attributable to various eye diseases in 1990 and 2019. We used two different counterfactual scenarios with respect to population structure and age-specific prevalence to assess the contribution of population growth and ageing to trends in vision loss. FINDINGS: In 2019, the age-standardised prevalence was 2·57% (uncertainty interval [UI] 2·28-2·86) for moderate vision impairment, 0·25% (0·22-0·29) for severe vision impairment, and 0·48% (0·43-0·54) for blindness in China, which were all below the global average, but the prevalence of moderate and severe vision impairment had increased more rapidly than in other G20 countries from 1990 to 2019. The prevalence of vision loss increased with age, and the main causes of vision loss varied across age groups. The leading causes of vision impairment in China were uncorrected refractive error, cataract, and macular degeneration in both 1990 and 2019 in the overall population. From 1990 to 2019, the number of people with moderate vision impairment increased by 133·67% (from 19·65 to 45·92 million), those with severe vision impairment increased by 147·14% (from 1·89 to 4·67 million), and those with blindness increased by 64·35% (from 5·29 to 8·69 million); in each case, 20·16% of the increase could be explained by population growth. The contributions to these changes by population ageing were 87·22% for moderate vision impairment, 116·06% for severe vision impairment, and 99·22% for blindness, and the contributions by age-specific prevalence were 26·29% for moderate vision impairment, 10·91% for severe vision impairment, and -55·04% for blindness. The prevalence and specific causes of vision loss differed across provinces. INTERPRETATION: Although a comprehensive national policy to prevent blindness is in place, public awareness of visual health needs improving, and reducing the prevalence of moderate and severe vision impairment should be prioritised in future work. FUNDING: China National Key Research and Development Programme and Beijing Municipal Special Funds for Medical Research on Public Welfare Development and Reform.
背景:视力丧失是中国一个重要的公共卫生问题,但对于其流行率和病因的国家和地区趋势,人们了解甚少,而这些信息可能会影响卫生政策。本研究旨在评估 1990 年和 2019 年中国视力损伤和失明的患病率、病因和地区分布。
方法:使用全球疾病、伤害和危险因素研究(GBD)2019 年的数据来估计中国中度和重度视力障碍和失明的患病率,并与其他 20 国集团(G20)国家进行比较。我们使用 GBD 方法系统地分析了中国省级的所有现有人口统计学和流行病学数据。我们比较了各省的年龄标准化患病率,并比较了 1990 年和 2019 年各种眼部疾病导致视力丧失比例的变化。我们使用两种不同的关于人口结构和特定年龄患病率的反事实情景来评估人口增长和老龄化对视力丧失趋势的贡献。
结果:2019 年,中国中度视力障碍的年龄标准化患病率为 2.57%(95%不确定区间[UI]2.28-2.86),重度视力障碍为 0.25%(0.22-0.29),失明为 0.48%(0.43-0.54),均低于全球平均水平,但从 1990 年到 2019 年,中度和重度视力障碍的患病率增长速度比其他 G20 国家更快。视力丧失的患病率随年龄增长而增加,不同年龄组的主要病因也有所不同。中国视力障碍的主要病因是未矫正的屈光不正、白内障和黄斑变性,这在 1990 年和 2019 年的总体人群中都是如此。从 1990 年到 2019 年,中度视力障碍患者增加了 133.67%(从 1965 万增加到 4592 万),重度视力障碍患者增加了 147.14%(从 189 万增加到 467 万),失明患者增加了 64.35%(从 529 万增加到 869 万);在每种情况下,增长的 20.16%可以用人口增长来解释。人口老龄化对中度视力障碍的贡献为 87.22%,对重度视力障碍的贡献为 116.06%,对失明的贡献为 99.22%,年龄特异性患病率对中度视力障碍的贡献为 26.29%,对重度视力障碍的贡献为 10.91%,对失明的贡献为-55.04%。视力丧失的患病率和具体病因在各省之间存在差异。
结论:尽管中国已经制定了全面的防盲国家政策,但公众对视觉健康的认识仍需提高,未来的工作应优先降低中度和重度视力障碍的患病率。
资助:中国国家重点研发计划和北京市医疗卫生公益事业发展专项基金。
Lancet Glob Health. 2017-10-11
Lancet Glob Health. 2013-11-11
Health Res Policy Syst. 2025-9-1
Transl Vis Sci Technol. 2025-8-1
Lancet Reg Health West Pac. 2025-6-11